| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 02/04/2010 | WO2010013494A1 Pharmaceutical composition comprising botulinum neurotoxin preparation incapable of being synaptically transported, and use thereof |
| 02/04/2010 | WO2010013474A1 Ceramide production promoter |
| 02/04/2010 | WO2010013204A1 Composition for regenerating senescent cutaneous and sub-cutaneous tissue, products and uses thereof |
| 02/04/2010 | WO2010013191A2 Cosmetic composition and process for regrowth of integumentary system |
| 02/04/2010 | WO2010013110A2 Composition comprising an association of active principles for use in the topical treatment of baldness |
| 02/04/2010 | WO2010013086A1 Phosphorylated dendrimers as antiinflammatory drugs |
| 02/04/2010 | WO2010013078A2 Pyrrolidinyl-alkyl-amide derivatives their preparation and their therapeutic application as ccr3 receptor ligands |
| 02/04/2010 | WO2010013044A1 Nalmefene and derivatives thereof for the treatment of skin disorders |
| 02/04/2010 | WO2010012720A1 Compositions for the prophylaxis and treatment of dermatological/mucosal diseases, and uses thereof |
| 02/04/2010 | WO2009151212A3 External preparation composition for skin comprising ginseng flower or ginseng seed extracts |
| 02/04/2010 | WO2009134404A3 Steroidal compounds as melanogenesis modifiers and uses thereof |
| 02/04/2010 | WO2009003283A8 Novel compounds, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same |
| 02/04/2010 | US20100029781 Methods for preparation of anti-acne formulation and compositions prepared thereby |
| 02/04/2010 | US20100029778 Hair and/or scalp treatment compositions |
| 02/04/2010 | US20100029766 Blends Comprising a Substituted Fatty Acid or a Derivative Thereof |
| 02/04/2010 | US20100029765 Topical aqueous composition comprising tretinoin |
| 02/04/2010 | US20100029762 Administration of adapalene and benzoyl peroxide for the long-term treatment of acne vulgaris |
| 02/04/2010 | US20100029728 Phosphodiesterase inhibitors |
| 02/04/2010 | US20100029722 Organic compounds |
| 02/04/2010 | US20100029709 Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 02/04/2010 | US20100029695 Method of treating dermatitis comprising administering a chymase inhibitor |
| 02/04/2010 | US20100029675 Pyrimidine-2, 4-diamine JAK2 Kinase inhibiting anti-inflammation use |
| 02/04/2010 | US20100029639 Ion channel modulating compounds and uses thereof |
| 02/04/2010 | US20100029631 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 02/04/2010 | US20100029602 Low-dose mometasone formulations |
| 02/04/2010 | US20100029600 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |
| 02/04/2010 | US20100029584 Process for producing a cellulose-based film to be used for skin and tissue lesions |
| 02/04/2010 | US20100029564 Novel process of solubilizing protein from a proteinaceous material and compositions thereof |
| 02/04/2010 | US20100029562 hG31P Expression System |
| 02/04/2010 | US20100029553 Microfluidic Device for Controlled Aggregation of Spider Silk |
| 02/04/2010 | US20100028463 Extract of stewartia koreana and use thereof |
| 02/04/2010 | US20100028460 Improvements in relation to cancer therapy |
| 02/04/2010 | US20100028445 Polymer |
| 02/04/2010 | US20100028437 Hyaluronic Acid-Based Gels Including Lidocaine |
| 02/04/2010 | US20100028413 Skin treatment strip |
| 02/04/2010 | US20100028411 Adhesive skin patch and method for evaluation of adhesive skin patch |
| 02/04/2010 | US20100028408 Method for sterilizing unheated raw honey, a honey-based wound care preparation, a wound care treatment product, and a biscuit based on honey |
| 02/04/2010 | US20100028407 Layered bio-adhesive compositions and uses thereof |
| 02/04/2010 | US20100028400 Pharmaceutical composition on the basis of stachytarpheta sp., a process for obtaining the same and its use for treating vitiligo |
| 02/04/2010 | US20100028399 Use of Polymers |
| 02/04/2010 | US20100028376 Pharmaceutical and cosmetic use of extracts from algae obtainable from saline hot water sources |
| 02/04/2010 | US20100028363 Methods for treating psoriasis |
| 02/04/2010 | US20100028349 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity |
| 02/04/2010 | US20100028317 Skin Repair Compositions Comprising Circadian Gene Activators And A Synergistic Combination Of Sirt1 Gene Activators |
| 02/04/2010 | US20100028313 Compositions and methods for treatment of skin disorders |
| 02/04/2010 | US20100028310 Composition for Transplantation Comprising Adipose Stem Cells or Adipocytes |
| 02/04/2010 | US20100028278 Use of chroman-4-one derivatives |
| 02/04/2010 | US20100028262 3,4-methylenedioxy-substituted chalcones as therapeutic agents |
| 02/04/2010 | US20100028257 Pharmaceutical compounds |
| 02/04/2010 | CA2732631A1 Pyrrolidinyl-alkyl-amide derivatives their preparation and their therapeutic application as ccr3 receptor ligands |
| 02/04/2010 | CA2732437A1 Toll-like receptor agonist formulations and their use |
| 02/04/2010 | CA2732340A1 Compositions for the prophylaxis and treatment of dermatological/mucosal diseases, and uses thereof |
| 02/04/2010 | CA2731358A1 5/5-or 5/6-membered condensed ring cycloalkylamine derivative |
| 02/03/2010 | EP2149375A1 Compositions for the treatment of dermatological diseases, and uses thereof |
| 02/03/2010 | EP2148876A1 Pyrazolone derivatives as pde4 inhibitors |
| 02/03/2010 | EP2148727A2 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, methods for the preparation thereof, and uses thereof |
| 02/03/2010 | EP2148726A1 Secreted frizzled related protein 3 for use in the inhibition of scarring |
| 02/03/2010 | EP2148687A2 Topical composition containing sacred water |
| 02/03/2010 | EP2148686A2 Novel active ingredient in cicatrization and use thereof |
| 02/03/2010 | EP1511742B1 Kinase inhibitors |
| 02/03/2010 | CN100586434C Anti-itching agent |
| 02/02/2010 | US7655797 Intermediates for making 2,4-pyrimidinediamine compounds |
| 02/02/2010 | US7655688 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 02/02/2010 | US7655680 (E)-3-[2-(3,4-diethoxyphenyl)thiazole-4-yl]-1-(2-methoxyphenyl)propenone; inhibiting the activity of phosphodiesterase 4, the production of tumor necrosis factor alpha, and the production of interleukin 4; atopic dermatitis |
| 02/02/2010 | US7655676 Selective activity against propionibacterium acne; minimum inhibitory concentration (MIC) against Propionibacterium acnes strains both sensitive and resistant to erythromycin and clindamycin and against a series Staphylococcus strains |
| 02/02/2010 | US7655674 Hedgehog antagonists that inhibit the hedgehog pathway in a smoothened gain-of-function cell with an IC50 within a factor of 20, 10, or even a factor of 5, of the IC50 with which they inhibit the hedgehog pathway in a patched-null cell |
| 02/02/2010 | US7655663 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 02/02/2010 | US7655656 crystalline 6-[[(3S,4R)-3,4-dihydro-3-hydroxy-6-[(3-hydroxypheny)sulfonyl]-2,2,3-trimethyl-2H-1-benzopyran-4-yl]oxy]-2-methyl-3(2H)-pyridazinone; industrial scale |
| 02/02/2010 | US7655425 Uses of a chemokine receptor able to bind to MCP-1, MIP-1α and/or RANTES |
| 02/02/2010 | US7655255 Topical composition for transdermal administration |
| 02/02/2010 | US7655251 Amphiphilicmonocatenary glycosylated hydrocarbon nitrones; oxidation resistance;free radical scavengers; neuroprotectants; cosmetic products for the skin, hair andnails; imunotherapy; antiinflammatory agents; Alzheimer's disease; Parkinson'sdisease; aging resistance; radiation injuries |
| 02/02/2010 | CA2494583C Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 02/02/2010 | CA2439051C Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
| 02/02/2010 | CA2418868C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 02/02/2010 | CA2410305C Preparations comprising combinations of enzyme inhibitors, and the use thereof |
| 02/02/2010 | CA2383412C Cationic liposome delivery of taxanes to angiogenic blood vessels |
| 02/02/2010 | CA2333963C Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds |
| 02/02/2010 | CA2311942C An antimicrobial composition |
| 01/28/2010 | WO2010011611A2 Antimicrobially-primed medicinal maggot therapy |
| 01/28/2010 | WO2010011541A2 Topical anti-inflammatory combination |
| 01/28/2010 | WO2010010949A1 Lipase inhibitor |
| 01/28/2010 | WO2010010299A2 Dermocosmetic composition, aesthetic treatment method using the composition, and use of the composition for lightening the pigmentation of the skin |
| 01/28/2010 | WO2010010168A1 Transdermal pharmaceutical compositions comprising danazol |
| 01/28/2010 | WO2010009667A1 Method for producing an extract of vitis vinifera having high orac values and the extract produced by said method |
| 01/28/2010 | WO2009128076A3 Methods of generating and using procollagen |
| 01/28/2010 | WO2009120365A3 Methods and compositions for the delivery of agents |
| 01/28/2010 | WO2009047826A8 Pharmaceutical composition comprising sucralphate and mesalazine |
| 01/28/2010 | US20100022997 Method and process for producing youthful-appearing, small-pored, and smooth skin |
| 01/28/2010 | US20100022783 Cyclohexanecarboxylic acid compound |
| 01/28/2010 | US20100022632 Use certain diterpene compounds in the treatment of androgen receptor-associated diseases |
| 01/28/2010 | US20100022604 Prophylactic or therapeutic agent for alopecia |
| 01/28/2010 | US20100022566 Quinazoline derivatives and pharmaceutical compositions thereof |
| 01/28/2010 | US20100022522 HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS |
| 01/28/2010 | US20100022461 Novel Derivatives of Cyclic Compound And The Use Thereof |
| 01/28/2010 | US20100022016 Polyamide nucleic acid derivatives and agents, and processes for preparing them |
| 01/28/2010 | US20100021571 Compositions and Methods for Treating Acne |
| 01/28/2010 | US20100021528 Conformable structured therapeutic dressing |
| 01/28/2010 | US20100021527 Collagen-related peptides and uses thereof and hemostatic foam substrates |
| 01/28/2010 | US20100021510 Neuronal exocytosis inhibiting peptides |
| 01/28/2010 | US20100021493 Extracts of aphanizomenon flos aquae and nutritional, cosmetic and pharmaceutical compositons containing the same |